How much does Ryeqo cost? Is it available in Shandong now?
Uterine fibroids are the most common benign tumors in adult women. They can disrupt uterine function in a variety of ways and may lead to uterine bleeding, anemia, infertility, embryo implantation defects, premature birth, labor obstruction, urinary incontinence, etc. On May 26, 2021, the compound preparation of relugolix (40 mg of this product, 1.0 mg of estradiol, 0.5 mg of norethindrone acetate) was jointly submitted by Pfizer and Myovant Sciences, and was approved by the FDA on May 26, 2021. Its trade name is Myfembree (), which is used to treat female uterine fibroids.
How much does Ryeqo cost? Is it available in Shandong now?
It is a pity that the editor of Medical Companion Travel can only tell you that the Ryeqo you are looking forward to is not available in China. This means that there will be no pharmacies and hospitals in Shandong selling this drug. This news may make everyone feel particularly sad. After all, the disease is at the forefront. Should we give up in spite of the difficulties?
At this time, many patients choose to purchase Ryeqo by purchasing drugs overseas, but they are often troubled by the authenticity of the drugs, language barriers, and high costs. Many patients think this may be the only way to buy Ryeqo. But the editor is here to tell you that you can choose to trust the domestic and overseas medical service organization Medical Companion Travel to help you purchase the medicine. On the one hand, the medicines purchased through Medical Companion Travel can save you a lot of trouble. On the other hand, the price of the medicine is much more cost-effective than buying medicine abroad, and the effects are also very impressive. For more information about Ryeqo, please contact Medical Companion Travel for details.
Note: The above information comes from the Internet and is compiled and edited by Medical Companion Travel (please correct me if there are any errors or omissions). It is only to provide information on the latest drugs on the market in the world and help Chinese patients understand the latest international new drug trends. It is only for internal discussion among medical staff and does not serve as any basis for medication. For specific medication guidelines, please consult the attending physician.
Recommended hot articles:
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)